Imm Cancer Research Results

Imm, immunostimulatory: Click to Expand ⟱

Source:

Type:

Enhance the immune response in patients.

Scientific Papers found: Click to Expand⟱

MushMait,

A phase I/II trial of a polysaccharide extract from Grifola frondosa (Maitake mushroom) in breast cancer patients: immunological effects

Trial,

BC,

34 postmenopausal breast cancer patients, free of disease after initial treatment, were enrolled sequentially in five cohorts.

Dose↝, *toxicity↓, Imm⇅, other↝, Dose↝, CD4+↑, IL2↑, IL10↑, TNF-α↑, IFN-γ↑, Imm↝,

Showing Research Papers: 1 to 1 of 1

* indicates research on normal cells as opposed to diseased cells
Total Research Paper Matches: 1

Pathway results for Effect on Cancer / Diseased Cells:

Transcription & Epigenetics(tgid=7) ⓘ

other↝, 1,

Immune & Inflammatory Signaling(tgid=16) ⓘ

CD4+↑, 1, IFN-γ↑, 1, IL10↑, 1, IL2↑, 1, Imm⇅, 1, Imm↝, 1, TNF-α↑, 1,

Drug Metabolism & Resistance(tgid=21) ⓘ

Dose↝, 2,
Total Targets: 9

Pathway results for Effect on Normal Cells:

Functional Outcomes(tgid=23) ⓘ

toxicity↓, 1,
Total Targets: 1

Scientific Paper Hit Count for: Imm, immunostimulatory

Query results interpretion may depend on "conditions" listed in the research papers.
Such Conditions may include : 
  -low or high Dose
  -format for product, such as nano of lipid formations
  -different cell line effects
  -synergies with other products 
  -if effect was for normal or cancerous cells

Filter Conditions: Pro/AntiFlg:%  IllCat:%  CanType:%  Cells:0  prod#:%  Target#:1332  State#:%  Dir#:3
  wNotes=0  sortOrder:rid,rpid